New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2013
08:43 EDTDNRDenbury Resources production appears quite strong, says Sterne Agee
After Denbury Resources preannounced its production and reserves yesterday, Sterne Agee expects the company's production to provide it with momentum going into 2013. The firm raised its price target on the stock to $22 from $20 and reiterates a Buy rating.
News For DNR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 21, 2015
08:45 EDTDNROn The Fly: Pre-market Movers
HIGHER: Atmel (ATML), up 15% after agreeing to be acquired by Dialog Semiconductor in a deal valued at approximately $4.6B, or the equivalent of $10.42 per Atmel share... uniQure (QURE), up 12% after announcing topline results of one-year follow-up data from a Phase I/II clinical trial in four Sanfilippo B syndrome patients... lululemon (LULU), up 3% after the stock was upgraded to Overweight at Morgan Stanley... Alcobra (ADHD), up 15% after announcing that the FDA has granted Fast Track designation to Metadoxine Extended Release for the treatment of Fragile X Syndrome... Denbury Resources (DNR), up 5% after announcing that its board has decided to suspend the company's current 6.25c per share quarterly cash dividend and reinstated the ability for the company to repurchase shares under its previously authorized share repurchase program, which was suspended in late 2014... TherapeuticsMD (TXMD), up 4% after Jefferies analyst Chris Howerton more than doubled his price target for shares to $15 from $7, citing a positive view Vagicap in vulvovaginal atrophy. LOWER: GoPro (GPRO), down 4% after Barron's contended in an article this weekend that the stock may slip another 30% despite its recent pullback... Weatherford (WFT), down 7.7% after announcing the launch of concurrent underwritten public offerings of ordinary shares and mandatory exchangeable subordinated notes for an expected combined amount of $1B... ImmunoGen (IMGN), down 4.7% after Morgan Stanley downgraded the stock to Underweight, stating that consensus estimates for its key asset, IMGN 853, remain too optimistic on the potential success of an upcoming Phase II study.
07:08 EDTDNRDenbury suspends 6.25c per share quarterly dividend
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use